Universal Acetylene Co Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 09-12-2024
- Paid Up Capital ₹ 2.05 M
as on 09-12-2024
- Company Age 46 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 5.54 M
as on 09-12-2024
- Revenue %
(FY 2020)
- Ebitda
- Net Worth -0.36%
(FY 2020)
- Total Assets -0.56%
(FY 2020)
About Universal Acetylene Co
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.05 M.
The company currently has active open charges totaling ₹5.54 M.
Samineni Rao, Nannapaneni Lakshmi, and Samineni Prasad serve as directors at the Company.
- CIN/LLPIN
U24119AP1978PTC002339
- Company No.
002339
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Aug 1978
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- LocationNa, Andhra Pradesh
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Universal Acetylene Co?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Samineni Rao | Director | 22-Aug-1978 | Current |
Nannapaneni Lakshmi | Director | 01-Mar-1997 | Current |
Samineni Prasad | Director | 19-Aug-1986 | Current |
Financial Performance of Universal Acetylene Co.
Universal Acetylene Co Pvt Ltd, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss | |||||||
Net Worth |
| ||||||
EBITDA |
What is the Ownership and Shareholding Structure of Universal Acetylene Co?
Unlock access to Universal Acetylene Co's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Mithra Oxygen Co Pvt LtdActive 43 years 11 months
Samineni Rao and Samineni Prasad are mutual person
Charges (Loans)
₹5.54 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.30 Cr
- Bank Of Baroda : 0.17 Cr
- The Indian Overseas Bank : 0.09 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
19 Feb 1988 | The Indian Overseas Bank | ₹0.90 M | Open |
28 May 1980 | Bank Of India | ₹1.30 M | Open |
31 Mar 1980 | Bank Of India | ₹1.67 M | Open |
07 Jul 1979 | Bank Of Baroda | ₹1.67 M | Open |
How Many Employees Work at Universal Acetylene Co?
Unlock and access historical data on people associated with Universal Acetylene Co, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Universal Acetylene Co, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Universal Acetylene Co's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.